N. Colombo

Publication List Details

Period

1990 - 2009

Number

35

Co-Authors

Surgical treatment of drug-resistant nocturnal frontal lobe epilepsy (2007)

Nobili, L., Francione, S., Mai, R., Cardinale, F., Castana, L., Tassi, L., ...

Of the cases with nocturnal frontal lobe epilepsy (NFLE) ∼30% are refractory to antiepileptic medication, with several patients suffering from the effects of both ongoing seizures and disrupted...

Electroclinical, MRI and neuropathological study of 10 patients with nodular heterotopia, with surgical outcomes (2005)

Tassi, L., Colombo, N., Cossu, M., Mai, R., Francione, S., Lo Russo, G., ...

We present the results of a retrospective study on 10 patients operated on for intractable epilepsy associated with nodular heterotopia as identified by high resolution MRI. Seven patients had...

Electroclinical, MRI and neuropathological study of 10 patients with nodular heterotopia, with surgical outcomes (2004)

Tassi, L., Colombo, N., Cossu, M., Mai, R., Francione, S., Lo Russo, G., ...

Summary We present the results of a retrospective study on 10 patients operated on for intractable epilepsy associated with nodular heterotopia as identified by high resolution MRI. Seven patients...

Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy (2004)

Cavaletti, G., Bogliun, G., Marzorati, L., Zincone, A., Piatti, M., Colombo, N., ...

Background: We investigated the possible use of clinical signs of chemotherapy-induced peripheral neurotoxicity (CIPN) or of nerve growth factor (NGF) circulating levels to predict the final outcome...

Electroclinical, MRI and neuropathological study of 10 patients with nodular heterotopia, with surgical outcomes (2004)

Tassi, L., Colombo, N., Cossu, M., Mai, R., Francione, S., Lo Russo, G., ...

Summary We present the results of a retrospective study on 10 patients operated on for intractable epilepsy associated with nodular heterotopia as identified by high resolution MRI. Seven patients...

Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial (2003)

Parmar, M.K., Ledermann, J.A., Colombo, N., Du Bois, A., Delaloye, J.F.

Background: Despite improvements in the treatment of ovarian cancer, most patients develop recurrent disease within 3 years of diagnosis. There is no agreed second-line treatment at relapse. We...

Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial (2002)

Parmar, M.K.B., Adams, M., Balestrino, M., Bertelsen, K., Bonazzi, C., Calvert, H., ...

Background: Previously, we have shown that the combination of cyclophosphamide, doxorubicin, and cisplatin (CAP) and singleagent carboplatin produce similar survival and progression-free survival...

Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome (2002)

Tassi, L., Colombo, N., Garbelli, R., Francione, S., Lo Russo, G., Mai, R., ...

Since the original description by Taylor, the term focal cortical dysplasia has been used to refer to a wide range of alterations of the cortical mantle. More recently, these conditions have been...

Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: An EORTC Gynecological Cancer Cooperative Group study (2001)

Vermorken, J. B., Zanetta, G., De Oliveira, C. F., Lacave, A. J., Teodorovic, I., ...

Purpose: Three previous mitomycin-cisplatin-based chemotherapy trials conducted within the EORTC Gynecological Cancer Cooperative Group (GCCG) in patients with disseminated squamous-cell carcinoma of...

Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer (1998)

Zanetta, G., Lissoni, A., Pellegrino, A., Sessa, C., Colombo, N., Gueli-Alletti, D., ...

Background: Neoadjuvant chemotherapy is increasingly being used for the treatment of bulky and locally-advanced cervical cancer. Cisplatin and ifosfamide are known to be effective in cervical cancer,...

The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer (1995)

Lent, M. Van, Buyse, M., Kobierska, A., Colombo, N., Favalli, G., ...

BACKGROUND. Although the value of primary cytoreductive surgery for epithelial ovarian cancer is beyond doubt, the value of debulking surgery after induction chemotherapy has not yet been defined. In...

Adjuvant treatment for early epithelial ovarian cancer: Results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P) (1995)

Bolis, G., Colombo, N., Pecorelli, S., Torri, V., Marsoni, S., Bonazzi, C., ...

Background From 1983 to 1990, 271 consecutive patients with stage I ovarian cancer entered two randomised trials, aimed at assessing the role of adjuvant chemotherapy after radical surgery in early...

Overexpression of p185 is not related to erbB2 amplification in ovarian cancer (1993)

Morali, F., Cattabeni, M., Tagliabue, E., Campiglio, M., Menard, S., Marzola, M., ...

Background: While in breast cancer the amplification and overexpression of the erbB2 gene has been reported in numerous studies and found to be correlated to poor prognosis, information about this...

Dose intensity (1993)

Ozols, R. F., Thigpen, J. T., Dauplat, J., Colombo, N., Piccart, M. J., Bertelsen, K., ...

Background The rationale for dose intensity is based on pre-clinical observations in experimental model systems of cancer as well as upon retrospective studies correlating the impact of dose...

Low-dose oral etoposide in epithelial cancer of the ovary (1993)

Marzola, M., Zucchetti, M., Colombo, N., Sessa, C., Pagani, O., D'Incalci, M., ...

Aims: To evaluate antitumour activity, toxicity, pharmacokinetics, and the pharmacodynamic relationship with neutropenia of low-dose oral etoposide (E) in patients (pts) with epithelial cancer of the...

In Vitro and In Vivo Effects of Cisplatin on the Generation of Lymphokine-Activated Killer Cells (1990)

Allavena, P., Pirovano, P., Bonazzi, C., Colombo, N., Mantovani, A., D'Incalci, M.

Pretreatment of human peripheral blood lymphocytes (PBL) with cisplatin (CDDP) before in vitro culture with interleukin-2 (IL-2) inhibited the generation of lymphokine-activated killer (LAK) cells...

Antibody-dependent and -independent cytotoxicity of human mononuclear phagocytes: defective stimulation of tumoricidal activity in milk macrophages.

Biondi, A, Peri, G, Colombo, N, Bolis, G, Mantovani, A

Human peripheral blood monocytes, milk macrophages and peritoneal exudate macrophages were purified by adherence. antibody-dependent cellular cytotoxicity (ADCC) was measured using the murine TLX9...

Prognostic factors in advanced epithelial ovarian cancer. (Gruppo Interregionale Cooperativo di Oncologia Ginecologica (GICOG)).

Marsoni, S., Torri, V., Valsecchi, M. G., Belloni, C., Bianchi, U., Bolis, G., ...

The data on 914 patients enrolled in four randomised trials in advanced ovarian cancer, consecutively conducted by the same cooperative group between 1978 and 1986, were analysed with the aims of:...

Effect of a streptococcal preparation (OK432) on natural killer activity of tumour-associated lymphoid cells in human ovarian carcinoma and on lysis of fresh ovarian tumour cells.

Colotta, F., Rambaldi, A., Colombo, N., Tabacchi, L., Introna, M., Mantovani, A.

The streptococcal preparation OK432 was studied for its effects on natural killer (NK) activity of peripheral blood lymphocytes (PBL) from normal donors and from ovarian cancer patients, and of...

Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group.

Aabo, K., Adams, M., Adnitt, P., Alberts, D. S., Athanazziou, A., Barley, V., ...

The purpose of this systematic study was to provide an up to date and reliable quantitative summary of the relative benefits of various types of chemotherapy (non-platinum vs platinum, single-agent...

A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis

Fruscio, R, Colombo, N, Lissoni, A A, Garbi, A, Fossati, R, Ieda', N, ...

To test the feasibility and efficacy of epirubicin and ifosfamide added to first-line chemotherapy with cisplatin and paclitaxel in a phase II randomised clinical trial. Patients with histologically...

Sentinel node biopsy in early vulvar cancer

Cicco, C De, Sideri, M, Bartolomei, M, Grana, C, Cremonesi, M, Fiorenza, M, ...

Lymph node pathologic status is the most important prognostic factor in vulvar cancer; however, complete inguinofemoral node dissection is associated with significant morbidity. Lymphoscintigraphy...

Diagnosis of persistent ovarian carcinoma with three-step immunoscintigraphy

Magnani, P, Fazio, F, Grana, C, Songini, C, Frigerio, L, Pecorelli, S, ...

The diagnosis of recurrent ovarian carcinoma is usually determined at surgical re-exploration since the main non-invasive diagnostic tests have low accuracy. It would be desirable to have a high...